Imelda — Clinical Trial Site

62 Registered trials

27 Currently recruiting

Organisation

Imelda

Location

Bonheiden, Belgium

Identifier

ORG-100040025

Address

Imeldalaan 9, 2820, Belgium

Departments

1101: Gastro-enterologie
3002: Neurology
Associatie Dialyse Endocrinologie
BE10003: Oncologie
Cardiac Surgery
Cardiologie
Cardiology
Center for Reproductive Medicine
Digestive Oncology
Endocrinologie
Endocrinology
Endocrinology and Nephrology
Gastro-enterologie
Gastro-Enterology
Gastro-oncology
Gastroenterology
Gastroenterology & Hepatology
Gastroenterology and Hepatology
GI Clinical Research Center
gynaecology
Imelda GI Clinical Research Center
Imeldaziekenhuis Bonheiden - Department of Gastroenterology
Intensive Care Medicine
Medical Oncology
Medical Oncology and Hematology
N/A
NA
Nephrology
Neurology
Neurology Department
Oncology
Rheumatology
Thoracic and vascular Surgery

Clinical trials at this site (62)

Search interface

Renal Lifecycle Trial: A Randomized Controlled Clinical Trial to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in … Recruiting

2023-508389-13-00 Combined endpoint of all-cause mortality, kidney failur 5 2022-11-08
Prevention of postoperative endoscopic disease recurrence in Crohn’s disease: a multicentric study that compares the systematic start of bio… Recruiting

2022-500311-39-00 Patients with Crohn's disease undergoing surgery and ha 6 2022-09-08
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC… Recruiting

2024-516336-97-00 METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA 4 2022-02-21
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Treatment with a Vitamin K Antagonist due to having a m 5 2021-10-19
Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on therapy inte… Recruiting

2023-505319-19-00 Traumatic brain injury 11 2021-09-01
A study of BMS-986504 in combination with Nab-p/Gem versus placebo in combination with Nab-p/Gem in untreated metastatic PDAC with homozygou… Ended

2025-522598-12-00 Untreated Metastatic Pancreatic Ductal Adenocarcinoma 10 2025-12-17
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Gastroesophageal Junction Adenocarcinoma 5 2025-07-31
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 W… Ended

2023-505110-14-00 Colorectal Cancer 4 2024-12-02
An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancer Ended

2023-508219-21-00 BTC - Biliary Tract Cancer 5 2024-09-12
A Study of Lepodisiran (LY3819469) in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Ended

2023-509190-23-00 Atherosclerotic Cardiovascular Disease Elevated lp(a) 5 2024-09-03
A study concerning the influence of tubal flushing with oil on pregnancy and live birth in women with fertility problems Ended

2023-508896-35-00 Infertile women with at least one patent tube at Hyster 6 2024-07-12
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-OUTCOMES) Ended

2023-508630-34-00 Overweight 5 2024-05-28
Subcutaneous infliximab after a previous intravenous dose optimization (AMARETTO trial) Ended

2023-508166-15-00 Ulcerative colitis (UC), Inflammatory bowel disease typ 6 2024-04-29
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
A Study of Tirzepatide (LY3298176) on the Reduction of Morbidity and Mortality in Adults With Obesity (SURMOUNT- MMO) Ended

2022-501744-15-00 Obesity, Overweight 5 2023-01-23
A research study to see how well CagriSema helps people with excess body weight lose weight Ended

2023-506929-11-00 Overweight and obesity 5 2022-10-17
LEGACY Ended

2023-504360-42-00 Non-ST-segment elevation acute coronary syndrome 6 2022-05-13
Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial of therapeutic escalation, the POMEROL tri… Ended

2023-508242-18-00 Crohn's disease 6 2021-12-21
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
An Open-Label Extension and long-term efficacy and safety monitoring study of patients with Crohn's disease previously included in the loss … Ended

2024-514326-23-00 Crohn's disease 11 2021-09-10
A Phase II clinical trial comparing the efficacy of RO7198457 versus watchful waiting in patients with ctDNA positive, resected Stage II (hi… Ended

2023-509516-28-00 Stage II/Stage III rectal cancer or Stage II (high risk 4 2021-02-22
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn’s Disease (VIVID-2) Ended

2022-502841-91-00 Crohn’s Disease 5 2020-08-12
A Study of combination of Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) compared to VELCADE, Lenalidomide, and … Ended

2023-506125-10-00 Multiple Myeloma 5 2018-12-24